S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

$8.71
+0.31 (+3.69%)
(As of 03/28/2024 ET)
Today's Range
$8.57
$9.09
50-Day Range
$7.80
$10.88
52-Week Range
$2.36
$13.62
Volume
272,318 shs
Average Volume
147,819 shs
Market Capitalization
$479.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Pulse Biosciences MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
15.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
0.93mentions of Pulse Biosciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.03 out of 5 stars

Medical Sector

828th out of 938 stocks

Surgical & Medical Instruments Industry

85th out of 94 stocks

PLSE stock logo

About Pulse Biosciences Stock (NASDAQ:PLSE)

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

PLSE Stock Price History

PLSE Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Pulse Biosciences (PLSE) to Release Earnings on Thursday
PLSE Apr 2024 25.000 call
PLSE Oct 2024 17.500 call
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
PLSE Oct 2024 12.500 call
PLSE Jul 2024 2.500 put
See More Headlines
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/30/2023
Today
3/28/2024
Next Earnings (Confirmed)
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
61
Year Founded
N/A

Profitability

Net Income
$-58,510,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700,000.00
Book Value
($0.06) per share

Miscellaneous

Free Float
16,690,000
Market Cap
$479.75 million
Optionable
Optionable
Beta
1.69
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Robert W. Duggan (Age 79)
    Executive Chairman
  • Mr. Kevin P. Danahy (Age 53)
    President & CEO
    Comp: $393.25k
  • Mr. Darrin R. Uecker (Age 58)
    CTO & Director
    Comp: $487.24k
  • Mr. Mitchell E. Levinson (Age 64)
    Chief Strategy Officer
    Comp: $361.34k
  • Dr. Richard Nuccitelli Ph.D.
    Chief Science Officer
  • Mr. Kenneth B. Stratton Esq. (Age 55)
    J.D., General Counsel & Corporate Secretary
  • Ms. Patty Perla
    Vice President of Human Resources
  • Mr. David Danitz
    Senior Vice President of Engineering
  • Dr. Gansevoort Dunnington M.D.
    Chief Medical Officer
  • Dr. Niv Ad M.D.
    Chief Science Officer of Cardiac Surgery

PLSE Stock Analysis - Frequently Asked Questions

How have PLSE shares performed in 2024?

Pulse Biosciences' stock was trading at $12.24 on January 1st, 2024. Since then, PLSE shares have decreased by 28.8% and is now trading at $8.71.
View the best growth stocks for 2024 here
.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc. (NASDAQ:PLSE) announced its quarterly earnings data on Thursday, March, 30th. The company reported ($0.24) EPS for the quarter. The firm earned ($0.01) million during the quarter.

What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?

2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA), Portola Pharmaceuticals (PTLA), Enphase Energy (ENPH) and Novavax (NVAX).

When did Pulse Biosciences IPO?

Pulse Biosciences (PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (1.19%), Vanguard Group Inc. (1.19%), Griffin Asset Management Inc. (0.47%), Northern Trust Corp (0.33%), Westside Investment Management Inc. (0.06%) and Nuveen Asset Management LLC (0.05%). Insiders that own company stock include Kevin Patrick Danahy, Mitchell E Levinson and Robert W Duggan.
View institutional ownership trends
.

How do I buy shares of Pulse Biosciences?

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PLSE) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners